MDRX - Robbins LLP Reminds Veradigm Inc. Investors of Pending Lead Plaintiff Deadline in MRDX Class Action | Benzinga
SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Veradigm Inc. (NASDAQ:MDRX) securities between February 26, 2021 and June 13, 2023. Veradigm (formerly Allscripts Healthcare Solutions, Inc.) is a healthcare technology company that offers electronic health records ("EHR"), financial management, population health management, and consumer solutions to over 300,000 U.S. healthcare providers.
For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
What is this Case About: Veradigm Inc. (MDRX) Misled Investors Regarding its Internal Controls Over Financial Reporting
According to the complaint, during the class period, defendants emphasized Veradigm's strong revenue, gross margin, and EBITDA growth to investors during the Company's quarterly earnings calls. These and similar statements during the class period were ...